Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/03/21/2850154/0/en/CAMP4-Therapeutics-Announces-Dosing-of-First-Participant-in-Phase-1-Clinical-Study-of-CMP-CPS-001-a-Potential-First-in-Class-Therapeutic-for-Urea-Cycle-Disorders.html
https://www.pharmaceutical-technology.com/news/camp4s-funding-influx-paves-the-way-for-tapping-regulatory-rna-to-treat-urea-cycle-disorders/
https://www.fiercebiotech.com/biotech/equipped-100m-new-cash-camp4-follows-trail-clinic-though-partners-may-soon-tag-along